Angiotropin Treatment Prevents Flap Necrosis and Enhances Dermal Regeneration in Rabbits
- 1 June 1989
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Surgery
- Vol. 124 (6) , 693-698
- https://doi.org/10.1001/archsurg.1989.01410060059012
Abstract
• Angiotropin is a potent angiogenesis factor isolated from the serum-free media of cultured, lectin-activated peripheral monocytes. In vitro, the purified substance stimulates migration, phenotypic differentiation, and tube formation, but not proliferation of capillary endothelial cells. When injected intradermally, angiotropin induces, in dose-dependent fashion, angiogenesis associated with skin hyperplasia. We have developed a flap model with insufficient blood supply and a model for contraction-free defect healing in rabbit skin. We show that (1) local pretreatment with angiotropin can prevent flap necrosis and (2) dermal regeneration after wounding can be augmented by angiotropin. From these results, we conclude that angiotropin might be of use as an adjuvant to healing in surgery. (Arch Surg1989;124:693-698)Keywords
This publication has 4 references indexed in Scilit:
- Purified monocyte‐derived angiogenic substance (angiotropin) stimulates migration, phenotypic changes, and “tube formation” but not proliferation of capillary endothelial cells in vitroJournal of Cellular Physiology, 1987
- Angiogenic FactorsScience, 1987
- A Unifying Theory of the Delay Phenomenon– Recovery from the Hyperadrenergic StateAnnals of Plastic Surgery, 1981
- Design of an artificial skin. I. Basic design principlesJournal of Biomedical Materials Research, 1980